Yo Taniguchi1,2, Haruka Nomoto1, Akiyoshi Takami3,4, Luis Espinoza5, Makoto Onizuka6, Koichi Kashiwase7, Yasuo Morishima8, Takahiro Fukuda9, Yoshihisa Kodera4, Noriko Doki10, Koichi Miyamura11, Takehiko Mori12, Shinji Nakao13, Eriko Morishita1,13 (1.Department of Clinical Laboratory Science, Kanazawa Univ., Kanazawa, Japan, 2.Department of Clinical Laboratory, NHO Kanazawa Medical Center, Kanazawa, 3.Division of Hematology, Aichi Medical Univ., Nagakute, 4.Hematopoietic Cell Transplantation Center, Aichi Medical Univ. Hospital, Nagakute, 5.Department of Hematology and Rheumatology, Kindai Univ., Higashi-Osaka, 6.Department of Hematology and Oncology, Tokai Univ., Isehara, 7.Japanese Red Cross Kanto-Koshinetsu Block Blood Center, Tokyo, 8.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, 9.Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital, Tokyo, 10.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, 11.Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, 12.Division of Hematology, Keio Univ., Tokyo, 13.Hematology/Respiratory Medicine, Kanazawa Univ., Kanazawa)
Session information
Poster Session
Fri.Oct,11
Poster Session 1-29 Transplant Outcomes (1)
Fri. Oct 11, 2019 5:40 PM - 6:20 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Yasuo Mori (Department of Medicine and Biosystemic Science, Kyusyu University, Fukuoka, Japan)
Yurika Mitsui, Daisuke Nagase, Naoki Onda, Ai Hirota, Hirofumi Irita, Kazuhiko Natori (Division of Hematology and Oncology, Toho Univ. Omori Medical Center)
Cancelled
Mitsuru Moriyama, Seiichiro Yoshizawa, Daigo Akahane, Hiroaki Fujimoto, Nahoko Furuya, Yuko Tanaka, Seiichiro Katagiri, Moritaka Gotoh, Akihiko Gotoh, Kazuma Ohyashiki (Hematol, Tokyo Med. Univ., Tokyo, Japan)
Masayuki Murai, Yoshitaka Inoue, Nao Nishimura, Miho Matsumoto, Asami Yamada, Miho Watanabe, Mikiko Izaki, Kisato Nosaka, Masao Matsuoka (Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan)
Masatoshi Sakurai1, Takehiko Mori1, Hitoji Uchiyama2, Hiroatsu Ago3, Koji Iwato4, Tetsuya Eto5, Hiromi Iwasaki6, Minoko Takanashi7, Tatsuo Ichinohe8, Yoshiko Atsuta9,10, Takahito Kawata11, Hiroyuki Takamatsu12, Satoshi Yamasaki6, Ritsuro Suzuki13 (1.Div. Hematol, Keio University School of Medicine, Tokyo, 2.Dept. Hematol., Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, 3.Dept. Hematol. Oncol., Shimane Prefectural Central Hospital, Shimane, 4.Dept. Hematol., Hiroshima Red Cross Hospital, Hiroshima, 5.Dept. Hematol., Hamanomachi Hospital, Fukuoka, 6.Dept. Hematol., NHO Kyushu Medical Center, Fukuoka, 7.Blood Service Headquarters, Japanese Red Cross Society, Tokyo, 8.Dept. Hematol. Oncol., RIRBM, Hiroshima Univ., Hiroshima, 9.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, 10.Dept. Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, 11.Dept. Hematol., Hyogo Prefectural Amagasaki General Medical Center, Hyogo, 12.Dept. Hematol., Kanazawa University Hospital, Kanazawa, 13.Dept. Oncol. Hematol., Shimane University Hospital, Shimane)
Mitsunori Ueno, Toshiro Kawakita, Taichi Hirano, Norikazu Mitsui, Tatsunori Sakai, Naoko Harada, Michihiro Hidaka (Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan)
Hironori Sugitani1, Norikazu Mitsui1, Toshiro Kawakita1, Yoshitaka Inoue2, Akira Kubota1, Taichi Hirano1, Yoshiko Inoue1, Naoko Harada1, Tatsunori Sakai1, Michihiro Hidaka1, Masao Matsuoka2 (1.Hematol., National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 2.Hematol., Kumamoto Univ., Kumamoto, Japan)
Kaori Niwa, Junya Hirayama, Tomoki Hattori, Taro Okuda, Souya Kitamura, Shingo Yamada, Keishiro Amano, Hidemi Toyoda, Shotaro Iwamoto, Hiroki Hori, Masahiro Hirayama (Pediatrics, Mie University, Mie, Japan)